1999
DOI: 10.1006/gyno.1999.5522
|View full text |Cite
|
Sign up to set email alerts
|

Fluorescence in Situ Hybridization in Cervical Smears: Detection of Numerical Aberrations of Chromosomes 7, 3, and X and Relationship to HPV Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
14
0

Year Published

2000
2000
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(15 citation statements)
references
References 19 publications
1
14
0
Order By: Relevance
“…Likewise, a gain of the long arm of chromosome 3 (3q) is found in 85% of cervical cancers (52)(53)(54)(55). The percentage of cells with this cytogenetic alteration increases with the degree of cellular dysplasia (21) and occurs before transition to overt invasive disease (56,57).…”
Section: Discussionmentioning
confidence: 99%
“…Likewise, a gain of the long arm of chromosome 3 (3q) is found in 85% of cervical cancers (52)(53)(54)(55). The percentage of cells with this cytogenetic alteration increases with the degree of cellular dysplasia (21) and occurs before transition to overt invasive disease (56,57).…”
Section: Discussionmentioning
confidence: 99%
“…approach has been applied to many different tumor types, including cervical cancer, mainly using repetitive probe sequences that detect the centromeres of human chromosomes. [21][22][23][24] We have now devised a multicolor fluorescence in situ hybridization (FISH) assay using three specific DNA probes. The design of the probe panel was solely based on the pattern of genomic imbalances in cervical cancers as detected by comparative genomic hybridization (CGH).…”
mentioning
confidence: 99%
“…We and others used fluorescence in situ hybridisation (FISH) to sensitively detect tumour cells regularly characterised by numeric chromosomal aberrations (Fiegl et al, 2000(Fiegl et al, , 2004van Oostenbrugge et al, 2000). By identification of tumour-associated aneuploidy, FISH analysis has been successfully applied in tumour aspirates, urine, cerebrospinal fluid, cervical smears, sputum, and effusions (Cajulis et al, 1994;Chen et al, 1995;Ichikawa et al, 1996;Schenk et al, 1997;Mian et al, 1999;Fiegl et al, 2000Fiegl et al, , 2004van Oostenbrugge et al, 2000).…”
mentioning
confidence: 99%